Press Release: Assure Announces Amendment to Credit Facility to Allow Funding of Second Tranche of the Senior Term Loan for Working Capital Purposes, Increasing Access to Previously Restricted Line of Credit
Press Release: Assure Announces Amendment to Credit Facility to Allow Funding of Second Tranche of the Senior Term Loan for Working Capital Purposes, Increasing Access to Previously Restricted Line of Credit
Assure Announces Amendment to Credit Facility to Allow Funding of Second Tranche of the Senior Term Loan for Working Capital Purposes, Increasing Access to Previously Restricted Line of Credit
Assue宣佈修訂信貸安排，允許為高級定期貸款的第二批提供資金用於營運資金，增加獲得以前受到限制的信貸額度的機會
DENVER, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services, is pleased to announce that it has entered into an amending agreement (the "Amending Agreement") to its Commitment Letter dated March 8, 2021 (the "Commitment Letter"), with Centurion Financial Trust, an investment trust managed by Centurion Asset Management Inc. ("Centurion") in respect of the Company's $11,000,000 credit facility (the "Credit Facility") with Centurion comprised of a $9,000,000 senior term loan (the "Senior Term Loan"), funded in two tranches of $6,000,000 and $3,000,000, and a $2,000,000 senior revolving loan (the "Revolving Loan"). The first tranche of the Senior Term Loan and the Revolving Loan were previously funded.
丹佛，2021年11月24日(環球通訊社)--Assue Holdings Corp.(“公司”或“Assue”)(納斯達克：IONM；術中神經監測服務提供商IOM(多倫多證券交易所股票代碼：IOM)高興地宣佈，它已與Centurion Financial Trust(由Centurion Asset Management Inc.管理的投資信託基金)就公司與Centurion的11,000,000美元信貸安排(“信貸安排”)簽訂了一項修訂協議(“修訂協議”)，其中包括900萬美元的優先定期貸款(“高級貸款”)。該承諾函於2021年3月8日提交給Centurion(以下簡稱“承諾函”)。Centurion Financial Trust是由Centurion Asset Management Inc.(以下簡稱“Centurion”)管理的一家投資信託基金，該信託基金由Centurion Asset Management Inc.(“Centurion”)管理。高級定期貸款的第一批和循環貸款之前已獲得資金。
Pursuant to the Amending Agreement, upon satisfaction of the conditions precedent set forth therein, the Company may now access the second tranche of the Senior Term Loan in the amount of $3,000,000 to fund organic growth and for general working capital purposes. The second tranche of the Senior Term Loan was previously reserved solely for funding acquisition transactions.
根據修訂協議，在滿足其中所載先決條件後，本公司現可取得高級定期貸款的第二期，金額為3,000,000美元，為有機增長提供資金及作一般營運資金用途。高級定期貸款的第二部分以前僅為收購交易預留資金。
"The amended Credit Facility is another step in our efforts to improve our capital structure as we accelerate our next phase of growth," said John A. Farlinger, Assure's executive chairman and CEO. "The amended Credit Facility provides the flexibility to enable Assure to continue to invest in our most promising 2022 growth initiatives including the previously announced system-wide contract with Premier, Inc., expanding our high-margin remote neurology platform and extending our operational footprint."
Assue公司執行主席兼首席執行官約翰·A·法林格説：“修訂後的信貸安排是我們努力改善資本結構的又一步，因為我們正在加速下一階段的增長。”修改後的信貸安排提供了靈活性，使Assured能夠繼續投資於我們最有希望的2022年增長計劃，包括之前宣佈的與Premier，Inc.的全系統合同，擴大我們高利潤率的遠程神經學平臺，並擴大我們的業務足跡。“
"Centurion believes in Assure's strategic direction, market potential and management's proven ability to deliver," said Daryl W. Boyce, Executive Vice President, Corporate Finance of Centurion. "We are pleased to continue our partnership with Assure on a capital solution to help grow the Company."
百夫長公司負責公司財務的執行副總裁達裏爾·W·博伊斯説：“百夫長相信Assue公司的戰略方向、市場潛力和管理層被證明的交付能力。我們很高興繼續與Assured公司就資本解決方案建立夥伴關係，以幫助公司發展。“
The second tranche of the Senior Term Loan will now be made available to the Company to fund organic growth initiatives and for general working capital purposes. Interest on the Credit Facility accrues at an annual rate equal to the greater of 9.5% per annum or the Royal Bank of Canada Prime Rate plus 7.05% per annum, calculated and compounded monthly in arrears and payable on the first business day of each month in arrears. In addition, and pursuant to the Credit Facility, the Company shall pay Centurion a monthly standby fee of 1.50% per annum on any undrawn balance of the Credit Facility calculated and compounded monthly in arrears and payable on the first business day of each month in arrears.
高級貸款的第二部分現在將提供給公司，為有機增長計劃提供資金，並用於一般營運資本目的。信貸安排的利息按年利率等於年息9.5釐或加拿大皇家銀行最優惠利率加年息7.05釐(兩者以較大者為準)累算，按月計算及複利，並於每月拖欠的第一個營業日支付。此外，根據信貸安排，公司應向Centurion支付每月拖欠的信貸安排未支取餘額的1.50%的每月待命費用，每年1.50%，並於每月拖欠的第一個營業日支付。
The Credit Facility matures on June 9, 2025, and is secured by a first ranking security interest in all of the present and future assets of the Company and certain of its subsidiaries and affiliates (collectively, the "Assure Group"). The Credit Facility is guaranteed by the Assure Group, as more particularly set out in the loan documents. A description of the Credit Facility and the related loan documents is available in the Company's Current Report on Form 8-K as filed with the United States Securities and Exchange Commission on June 16, 2021, under the Company's issuer profile at www.sec.gov and in the corresponding documents filed on SEDAR at www.sedar.com. The Company will file a Current Report on Form 8-K regarding the Amending Agreement within 4 business days. The Amending Agreement remains subject to the approval of the TSX Venture Exchange ("TSXV").
信貸安排將於2025年6月9日到期，並以本公司及其若干附屬公司和聯營公司(統稱為“擔保集團”)目前和未來所有資產的一級擔保權益為抵押。信貸安排由Assured Group提供擔保，貸款文件中有更詳細的規定。對信貸安排和相關貸款文件的描述可在公司於2021年6月16日提交給美國證券交易委員會的8-K表格的當前報告中獲得，在公司的發行人簡介(www.sec.gov)下，以及在SEDAR(www.sedar.com)上提交的相應文件中。公司將在4個工作日內提交關於修訂協議的8-K表格的最新報告。修訂協議仍有待多倫多證券交易所創業板(“多倫多證券交易所”)的批准。
About Assure Holdings
關於Assue Holdings
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned The Joint Commission's Gold Seal of Approval(R).
Assure Holdings Corp.是一家總部位於科羅拉多州的公司，與神經外科醫生和整形外科脊柱外科醫生合作，提供一整套服務，支持侵入性手術期間的術中神經監測活動。Assure公司僱傭了自己的技術人員，並使用自己最先進的監測設備，處理100%的術中神經監測計劃和設置，以及提供的所有技術服務的賬單。Assure神經監測被公認為提供業內最高水平的患者護理，並獲得了聯合委員會的金色批准(註冊商標)。
Forward-Looking Statements
前瞻性陳述
This news release may contain "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects, " "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements include but are not limited to the future funding of the second tranche upon satisfaction of the conditions precedent in the Amending Agreement and the Company's intended use of the funds from the second tranche and future growth of the Company's business. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks regarding satisfaction of the conditions precedent in the Amending Agreement for the second tranche to be funded, risks regarding the Company's future compliance with the covenants of the Credit Facility and risk regarding the Company's future operations, the risk that the Company may not receive the approval of the TSXV in respect of the Amending Agreement, the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company's operations and economic activity in general, and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 30, 2021, and with the Canadian securities regulators and available on the Company's profiles on EDGAR at www.sec.gov and SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
本新聞稿可能包含適用證券法所指的“前瞻性陳述”。前瞻性陳述一般可以通過使用“預期”、“預期”、“打算”、“計劃”、“應該”、“可能”、“將會”、“可能”、“將會”、“相信”、“估計”、“潛在”、“目標”或“繼續”以及變體或類似的表述來識別。這些陳述包括但不限於，在修訂協議的先決條件得到滿足後，第二批資金的未來資金，以及公司對第二批資金的預期用途，以及公司業務的未來增長。這些陳述是基於管理層目前的預期和信念，會受到某些風險和不確定因素的影響，這些風險和不確定因素可能導致實際結果與前瞻性陳述中描述的大不相同。這些風險和不確定性包括但不限於：滿足第二期融資修訂協議中的先決條件的風險；本公司未來遵守信貸安排契諾的風險以及本公司未來運營的風險；本公司可能得不到修訂協議的批准的風險；圍繞新冠肺炎擴散的不確定性以及它將對本公司的運營和整體經濟活動造成的影響；以及我們在提交給美國證券交易委員會的最新年度和季度報告中討論的風險和不確定性。包括我們於2021年3月30日提交給加拿大證券監管機構的Form 10-K年度報告，並可在公司www.sec.gov上的Edgar和www.sedar.com上的SEDAR上查閲, 這些風險和不確定性通過引用併入本文。提醒讀者不要過度依賴前瞻性陳述。除非法律要求，否則Assured不打算也不承擔義務更新任何前瞻性陳述，以反映特別是新信息或未來事件。
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所創業板交易所及其監管服務提供商(該術語在多倫多證券交易所創業板政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Contact
聯繫人
Scott Kozak, Investor and Media Relations
斯科特·科扎克(Scott Kozak)，投資者和媒體關係
Assure Holdings Corp.
Assue Holdings Corp.
1-720-287-3093
1-720-287-3093
Scott.Kozak@assureiom.com
郵箱：Scott.Kozak@assureiom.com
John Farlinger, Chief Executive Officer
首席執行官約翰·法林格(John Farlinger)
Assure Holdings Corp.
Assue Holdings Corp.
1-604-763-7565
1-604-763-7565
John.Farlinger@assureiom.com
郵箱：John.Farlinger@assureiom.com
譯文內容由第三人軟體翻譯。